secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001493152-25-007902
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed raises $2.37M via PIPE of common stock and pre-funded warrants with Veris subsidiary shares
--------------------------------------------------------------------------------

- Sale of 2,574,350 shares and 756,734 pre-funded warrants at $0.7115/unit; Veris issues 677,143 shares to investors.
- Gross proceeds of $2.37M; proceeds to fund Veris' implantable physiological monitor and working capital.
- Company grants anti-dilution protection via additional Veris shares; restricts indebtedness until Aug 18, 2026.
- Registration rights granted; stockholder vote required for warrant shares by June 30, 2025.
- Transaction exempt under Section 4(a)(2) and Regulation D; no public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/0001493152-25-007902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225007902/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-007902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer